Association of Mild Cognitive Impairment With Exposure to General Anesthesia for Surgical and Nonsurgical Procedures: A Population-Based Study

Mayo Clinic Proceedings

Volumn 91, Issue 2, 2016, Pages 208-217

  Sprung, Juraj ^a   Roberts, Rosebud O ^a   Knopman, David S ^a   Olive, Diana M ^a   Gappa, Jennie L ^a   Sifuentes, Valerie L ^a   Behrend, Travis L ^a   Farmer, Joel D ^a   Weingarten, Toby N ^a   Hanson, Andrew C ^a   Schroeder, Darrell R ^a   Petersen, Ronald C ^a   Warner, David O ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; ARTICLE; CLINICAL DEMENTIA RATING SCALE; COGNITION; COHORT ANALYSIS; DEMENTIA; DEMENTIA ASSESSMENT; DISEASE ASSOCIATION; EXPOSURE; FEMALE; FOLLOW UP; GENERAL ANESTHESIA; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINNESOTA; OUTCOME ASSESSMENT; POPULATION RESEARCH; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; ADULT; ADVERSE EFFECTS; LONG TERM ADVERSE EFFECTS; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; OPERATION DURATION; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SURGERY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANESTHESIA, GENERAL; FEMALE; HUMANS; INCIDENCE; LONG TERM ADVERSE EFFECTS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; MINNESOTA; NEUROPSYCHOLOGICAL TESTS; OPERATIVE TIME; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SURGICAL PROCEDURES, OPERATIVE;

EID: 84974701605     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2015.10.023     Document Type: Article

References (43)

1. 1 Moller, J.T., Cluitmans, P., Rasmussen, L.S., et al. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators: International Study of Post-Operative Cognitive Dysfunction. Lancet 351:9106 (1998), 857–861.
2. 2 Avidan, M.S., Evers, A.S., Review of clinical evidence for persistent cognitive decline or incident dementia attributable to surgery or general anesthesia. J Alzheimers Dis 24:2 (2011), 201–216.
3. 3 Vanderweyde, T., Bednar, M.M., Forman, S.A., Wolozin, B., Iatrogenic risk factors for Alzheimer's disease: surgery and anesthesia. J Alzheimers Dis 22:suppl 3 (2010), 91–104.
4. 4 Xie, Z., Dong, Y., Maeda, U., et al. Isoflurane-induced apoptosis: a potential pathogenic link between delirium and dementia. J Gerontol A Biol Sci Med Sci 61:12 (2006), 1300–1306.
5. 5 Wan, Y., Xu, J., Ma, D., Zeng, Y., Cibelli, M., Maze, M., Postoperative impairment of cognitive function in rats: a possible role for cytokine-mediated inflammation in the hippocampus. Anesthesiology 106:3 (2007), 436–443.
6. 6 Crosby, C., Culley, D.J., Baxter, M.G., Yukhananov, R., Crosby, G., Spatial memory performance 2 weeks after general anesthesia in adult rats. Anesth Analg 101:5 (2005), 1389–1392.
7. 7 Seitz, D.P., Shah, P.S., Herrmann, N., Beyene, J., Siddiqui, N., Exposure to general anesthesia and risk of Alzheimer's disease: a systematic review and meta-analysis. BMC Geriatr, 11, 2011, 83.
8. 8 Sprung, J., Jankowski, C.J., Roberts, R.O., et al. Anesthesia and incident dementia: a population-based, nested, case-control study. Mayo Clin Proc 88:6 (2013), 552–561.
9. 9 Avidan, M.S., Searleman, A.C., Storandt, M., et al. Long-term cognitive decline in older subjects was not attributable to noncardiac surgery or major illness. Anesthesiology 111:5 (2009), 964–970.
10. 10 Dijkstra, J.B., Van Boxtel, M.P., Houx, P.J., Jolles, J., An operation under general anesthesia as a risk factor for age-related cognitive decline: results from a large cross-sectional population study. J Am Geriatr Soc 46:10 (1998), 1258–1265.
11. 11 Eckenhoff, R.G., Laudansky, K.F., Anesthesia, surgery, illness and Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 47 (2013), 162–166.
12. 12 Ehlenbach, W.J., Hough, C.L., Crane, P.K., et al. Association between acute care and critical illness hospitalization and cognitive function in older adults. JAMA 303:8 (2010), 763–770.
13. 13 Petersen, R.C., Smith, G.E., Waring, S.C., Ivnik, R.J., Tangalos, E.G., Kokmen, E., Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56:3 (1999), 303–308.
14. 14 Petersen, R.C., Clinical practice: mild cognitive impairment. N Engl J Med 364:23 (2011), 2227–2234.
15. 15 Roberts, R.O., Geda, Y.E., Knopman, D.S., et al. The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology 30:1 (2008), 58–69.
16. 16 Petersen, R.C., Roberts, R.O., Knopman, D.S., et al. Prevalence of mild cognitive impairment is higher in men: The Mayo Clinic Study of Aging. Neurology 75:10 (2010), 889–897.
17. 17 Roberts, R.O., Geda, Y.E., Knopman, D.S., et al. The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging. Neurology 78:5 (2012), 342–351.
18. 18 Pankratz, V.S., Roberts, R.O., Mielke, M.M., et al. Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging. Neurology 84:14 (2015), 1433–1442.
19. 19 Rocca, W.A., Yawn, B.P., St Sauver, J.L., Grossardt, B.R., Melton, L.J., History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. Mayo Clin Proc 87:12 (2012), 1202–1213.
20. 20 Roberts, R.O., Cha, R.H., Knopman, D.S., Petersen, R.C., Rocca, W.A., Postmenopausal estrogen therapy and Alzheimer disease: overall negative findings. Alzheimer Dis Assoc Disord 20:3 (2006), 141–146.
21. 21 Roberts, R.O., Petersen, R.C., Subjective complaints in mild cognitive impairment make a difference. Acta Psychiatr Scand 121:4 (2010), 241–242.
22. 22 Rocca, W.A., Cha, R.H., Waring, S.C., Kokmen, E., Incidence of dementia and Alzheimer's disease: a reanalysis of data from Rochester, Minnesota, 1975-1984. Am J Epidemiol 148:1 (1998), 51–62.
23. 23 Rocca, W.A., Petersen, R.C., Knopman, D.S., et al. Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States. Alzheimers Dement 7:1 (2011), 80–93.
24. 24 Kokmen, E., Smith, G.E., Petersen, R.C., Tangalos, E., Ivnik, R.C., The short test of mental status. Correlations with standardized psychometric testing. Arch Neurol 48:7 (1991), 725–728.
25. 25 Hachinski, V.C., Iliff, L.D., Zilhka, E., et al. Cerebral blood flow in dementia. Arch Neurol 32:9 (1975), 632–637.
26. 26 Rosen, W.G., Terry, R.D., Fuld, P.A., Katzman, R., Peck, A., Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 7:5 (1980), 486–488.
27. 27 Fahn, S., Elton, R.L., Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. Fahn, S., Marsden, C.D., Calne, D.B., Goldstein, M., (eds.) Recent Developments in Parkinson's Disease, 2, 1987, MacMillan Healthcare Information, Florham Park, NJ, 153–163.
28. 28 Wechsler, D.A., Wechsler Memory Scale–Revised. 1987, Psychological Corp, New York, NY.
29. 29 Morris, J.C., The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43:11 (1993), 2412–2414.
30. 30 Pfeffer, R.I., Kurosaki, T.T., Harrah, C.H. Jr., Chance, J.M., Filos, S., Measurement of functional activities in older adults in the community. J Gerontol 37:3 (1982), 323–329.
31. 31 Petersen, R.C., Mild cognitive impairment as a diagnostic entity. J Intern Med 256:3 (2004), 183–194.
32. 32 Harris, P.A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., Conde, J.G., Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42:2 (2009), 377–381.
33. 33 Petersen, R.C., Smith, G.E., Ivnik, R.J., et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 273:16 (1995), 1274–1278.
34. 34 Bilotta, F., Doronzio, A., Stazi, E., et al. Postoperative cognitive dysfunction: toward the Alzheimer's disease pathomechanism hypothesis. J Alzheimers Dis 22:suppl 3 (2010), 81–89.
35. 35 Newman, S., Stygall, J., Hirani, S., Shaefi, S., Maze, M., Postoperative cognitive dysfunction after noncardiac surgery: a systematic review. Anesthesiology 106:3 (2007), 572–590.
36. 36 Newman, M.F., Kirchner, J.L., Phillips-Bute, B., et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 344:6 (2001), 395–402.
37. 37 Lee, T.A., Wolozin, B., Weiss, K.B., Bednar, M.M., Assessment of the emergence of Alzheimer's disease following coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty. J Alzheimers Dis 7:4 (2005), 319–324.
38. 38 Selnes, O.A., Royall, R.M., Grega, M.A., Borowicz, L.M. Jr., Quaskey, S., McKhann, G.M., Cognitive changes 5 years after coronary artery bypass grafting: is there evidence of late decline?. Arch Neurol 58:4 (2001), 598–604.
39. 39 Elenkov, I.J., Iezzoni, D.G., Daly, A., Harris, A.G., Chrousos, G.P., Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 12:5 (2005), 255–269.
40. 40 Jackson, J.C., Gordon, S.M., Hart, R.P., Hopkins, R.O., Ely, E.W., The association between delirium and cognitive decline: a review of the empirical literature. Neuropsychol Rev 14:2 (2004), 87–98.
41. 41 Ghoneim, M.M., Block, R.I., Clinical, methodological and theoretical issues in the assessment of cognition after anaesthesia and surgery: a review. Eur J Anaesthesiol 29:9 (2012), 409–422.
42. 42 Zanetti, M., Ballabio, C., Abbate, C., Cutaia, C., Vergani, C., Bergamaschini, L., Mild cognitive impairment subtypes and vascular dementia in community-dwelling elderly people: a 3-year follow-up study. J Am Geriatr Soc 54:4 (2006), 580–586.
43. 43 Casserly, I., Topol, E., Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. Lancet 363:9415 (2004), 1139–1146.